Sun Jian, Ning Xueping, Cui Lanyu, Ling Min, Xu Xiaoping, He Shengbin
School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi 530021, China.
Analyst. 2020 Oct 21;145(20):6541-6548. doi: 10.1039/d0an00585a. Epub 2020 Aug 10.
Enzyme-linked immunosorbent assay (ELISA) is an economic and easy operation technique that has been widely used for the detection of protein in industry. However, the low loading capacity of the enzyme reporter has contributed to the low sensitivity of traditional ELISA, and the cross-linking procedures of the enzyme-labeled antibody in ELISA methods can lead to the inactivation of the enzyme, which will further decrease the sensitivity. To address this issue, herein we fabricated "carrier-free" nanoparticles to obtain a horseradish peroxidase (HRP) labelled reporter with a high HRP loading capacity. A disulphide-containing bis-N-hydroxy succinimide (NHS) crosslinker (NHS-SS-NHS) was used to control the link and release of traceless HRPs, thus without reduction of its enzymatic activity. The HRP nanoparticle (NanoHRP) was successfully applied for dot blotting and ELISA. When carcinoembryonic antigen (CEA) was used as a target, the detection limit of the NanoHRP-based ELISA was 0.005 ng mL, which was about 400 times more sensitive than traditional ELISA. A good correlation between the CEA concentrations and the response values measured by NanoHRP ELISA was obtained in the range of 0.005 to 1 ng mL. This concept could be exploited to improve ELISA tests, especially those requiring a high accuracy, to facilitate physicians in deciding the appropriate medical treatment.
酶联免疫吸附测定(ELISA)是一种经济且操作简便的技术,已在工业上广泛用于蛋白质检测。然而,酶报告分子的低负载量导致传统ELISA的灵敏度较低,并且ELISA方法中酶标记抗体的交联过程会导致酶失活,这将进一步降低灵敏度。为了解决这个问题,我们在此制备了“无载体”纳米颗粒,以获得具有高辣根过氧化物酶(HRP)负载量的HRP标记报告分子。使用含二硫键的双N-羟基琥珀酰亚胺(NHS)交联剂(NHS-SS-NHS)来控制无痕HRP的连接和释放,从而不降低其酶活性。HRP纳米颗粒(NanoHRP)已成功应用于斑点印迹和ELISA。以癌胚抗原(CEA)为靶标时,基于NanoHRP的ELISA的检测限为0.005 ng/mL,比传统ELISA灵敏约400倍。在0.005至1 ng/mL范围内,CEA浓度与通过NanoHRP ELISA测量的响应值之间具有良好的相关性。这一概念可用于改进ELISA检测,尤其是那些需要高精度的检测,以帮助医生确定合适的治疗方案。